Johnston S - Search Results

1

Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast Cancer.

Lee CK, Davies L, Gebski VJ, Lord SJ, Di Leo A, Johnston S, Geyer C Jr, Cameron D, Press MF, Ellis C, Loi S, Marschner I, Simes J, de Souza P. Lee CK, et al. Among authors: johnston s. J Clin Oncol. 2016 Mar 20;34(9):936-44. doi: 10.1200/JCO.2015.62.4767. Epub 2016 Jan 25. J Clin Oncol. 2016. PMID: 26811533

2

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.

Newby JC, Johnston SR, Smith IE, Dowsett M. Newby JC, et al. Among authors: johnston sr. Clin Cancer Res. 1997 Sep;3(9):1643-51. Clin Cancer Res. 1997. PMID: 9815855

3

Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.

Dowsett M, Pfister C, Johnston SR, Miles DW, Houston SJ, Verbeek JA, Gundacker H, Sioufi A, Smith IE. Dowsett M, et al. Among authors: johnston sr. Clin Cancer Res. 1999 Sep;5(9):2338-43. Clin Cancer Res. 1999. PMID: 10499602 Clinical Trial.

4

Low-dose oral fluorouracil with eniluracil as first-line chemotherapy against advanced breast cancer: a phase II study.

Smith IE, Johnston SR, O'Brien ME, Hickish TF, de Boer RH, Norton A, Cirkel DT, Barton CM. Smith IE, et al. Among authors: johnston sr. J Clin Oncol. 2000 Jun;18(12):2378-84. doi: 10.1200/JCO.2000.18.12.2378. J Clin Oncol. 2000. PMID: 10856097 Clinical Trial.

5

Multimodality therapy in inflammatory breast cancer: is there a place for surgery?

De Boer RH, Allum WH, Ebbs SR, Gui GP, Johnston SR, Sacks NP, Walsh G, Ashley S, Smith IE. De Boer RH, et al. Among authors: johnston sr. Ann Oncol. 2000 Sep;11(9):1147-53. doi: 10.1023/a:1008374931854. Ann Oncol. 2000. PMID: 11061610 Free article.

6

Recurrent locally advanced breast cancer: the treatment of chest wall disease with further chemotherapy.

Saunders Y, Stebbing J, Broadley K, Johnston SR. Saunders Y, et al. Among authors: johnston sr. Clin Oncol (R Coll Radiol). 2001;13(3):195-9. doi: 10.1053/clon.2001.9252. Clin Oncol (R Coll Radiol). 2001. PMID: 11527294

7

Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.

Johnston SR. Johnston SR. Clin Cancer Res. 2001 Dec;7(12 Suppl):4376s-4387s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916228 Review.

8

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer.

De Boer RH, Eisen TG, Ellis PA, Johnston SR, Walsh G, Ashley S, Smith IE. De Boer RH, et al. Among authors: johnston sr. Ann Oncol. 2002 Jun;13(6):889-94. doi: 10.1093/annonc/mdf150. Ann Oncol. 2002. PMID: 12123334 Free article. Clinical Trial.

9

Breast cancer: metastatic.

Johnston S, Stebbing J. Johnston S, et al. Clin Evid. 2002 Jun;(7):1579-602. Clin Evid. 2002. PMID: 12230774 Updated. Review. No abstract available.

10

Breast cancer: non-metastatic.

Dixon JM, Gregory K, Johnston S, Rodger A. Dixon JM, et al. Among authors: johnston s. Clin Evid. 2002 Jun;(7):1603-30. Clin Evid. 2002. PMID: 12230775 Updated. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,327 results

Search Page